Gulf Medical Projects

Gulf Medical Projects Company

GMPCStocksAbu Dhabi Securities ExchangeHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	1.66B	1.36B	1.47B	1.34B	1.51B
Market Cap Growth	+20.2%	-7.6%	+9.4%	-11.1%	+27.1%
Enterprise Value	1.49B	1.23B	1.35B	1.28B	1.45B
Last Close Price	2.38	1.80	1.81	1.57	1.68
Valuation Multiples
PE Ratio	15.52	12.50	18.84	22.44	41.25
PS Ratio	2.13	1.77	2.17	2.36	3.00
PB Ratio	1.38	1.01	1.17	1.14	1.34
P/TBV Ratio	1.54	1.11	1.26	1.21	1.41
P/FCF Ratio	17.69	11.96	22.15	18.31	23.66
P/OCF Ratio	13.00	9.68	16.87	15.13	19.84
EV/Sales Ratio	1.90	1.61	2.00	2.25	2.87
EV/EBITDA Ratio	14.03	11.88	13.81	17.92	31.20
EV/EBIT Ratio	19.59	16.14	18.71	27.24	65.55
EV/FCF Ratio	15.80	10.88	20.41	17.49	22.65
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.06	0.06	0.06	0.11	0.20
Debt / FCF Ratio	0.06	0.06	0.09	0.11	0.15
Net Debt / Equity Ratio	-0.21	-0.21	-0.18	-0.13	-0.12
Net Debt / EBITDA Ratio	-2.68	-2.68	-2.34	-2.15	-3.00
Net Debt / FCF Ratio	-2.45	-2.45	-3.47	-2.10	-2.18
Efficiency & Liquidity
Asset Turnover	0.51	0.51	0.48	0.43	0.39
Inventory Turnover	24.73	24.73	29.55	26.60	25.13
Quick Ratio	2.30	2.30	2.41	1.79	1.79
Current Ratio	2.52	2.52	2.59	1.94	1.98
Returns & Yields
Return on Equity (ROE)	+10.4%	+10.4%	+8.2%	+6.5%	+3.9%
Return on Assets (ROA)	+3.2%	+3.2%	+3.2%	+2.2%	+1.1%
Return on Invested Capital (ROIC)	+6.7%	+6.7%	+6.5%	+4.7%	+2.2%
Return on Capital Employed (ROCE)	+5.6%	+5.6%	+5.6%	+3.9%	+1.9%
Earnings Yield	+6.4%	+8.0%	+5.3%	+4.5%	+2.4%
FCF Yield	+5.7%	+8.4%	+4.5%	+5.5%	+4.2%
Dividend Yield	+6.8%	+9.4%	+8.3%	+6.4%	+5.9%
Payout Ratio	—	+96.6%	+89.7%	+116.9%	+191.0%
Total Shareholder Return	+6.8%	+9.4%	+8.3%	+6.4%	+5.9%

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	1.66B	1.36B	1.47B	1.34B	1.51B
Market Cap Growth	+20.2%	-7.6%	+9.4%	-11.1%	+27.1%
Enterprise Value	1.49B	1.23B	1.35B	1.28B	1.45B
Last Close Price	2.38	1.80	1.81	1.57	1.68
Valuation Multiples
PE Ratio	15.52	12.50	18.84	22.44	41.25
PS Ratio	2.13	1.77	2.17	2.36	3.00
PB Ratio	1.38	1.01	1.17	1.14	1.34
P/TBV Ratio	1.54	1.11	1.26	1.21	1.41
P/FCF Ratio	17.69	11.96	22.15	18.31	23.66
P/OCF Ratio	13.00	9.68	16.87	15.13	19.84
EV/Sales Ratio	1.90	1.61	2.00	2.25	2.87
EV/EBITDA Ratio	14.03	11.88	13.81	17.92	31.20
EV/EBIT Ratio	19.59	16.14	18.71	27.24	65.55
EV/FCF Ratio	15.80	10.88	20.41	17.49	22.65
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.06	0.06	0.06	0.11	0.20
Debt / FCF Ratio	0.06	0.06	0.09	0.11	0.15
Net Debt / Equity Ratio	-0.21	-0.21	-0.18	-0.13	-0.12
Net Debt / EBITDA Ratio	-2.68	-2.68	-2.34	-2.15	-3.00
Net Debt / FCF Ratio	-2.45	-2.45	-3.47	-2.10	-2.18
Efficiency & Liquidity
Asset Turnover	0.51	0.51	0.48	0.43	0.39
Inventory Turnover	24.73	24.73	29.55	26.60	25.13
Quick Ratio	2.30	2.30	2.41	1.79	1.79
Current Ratio	2.52	2.52	2.59	1.94	1.98
Returns & Yields
Return on Equity (ROE)	+10.4%	+10.4%	+8.2%	+6.5%	+3.9%
Return on Assets (ROA)	+3.2%	+3.2%	+3.2%	+2.2%	+1.1%
Return on Invested Capital (ROIC)	+6.7%	+6.7%	+6.5%	+4.7%	+2.2%
Return on Capital Employed (ROCE)	+5.6%	+5.6%	+5.6%	+3.9%	+1.9%
Earnings Yield	+6.4%	+8.0%	+5.3%	+4.5%	+2.4%
FCF Yield	+5.7%	+8.4%	+4.5%	+5.5%	+4.2%
Dividend Yield	+6.8%	+9.4%	+8.3%	+6.4%	+5.9%
Payout Ratio	—	+96.6%	+89.7%	+116.9%	+191.0%
Total Shareholder Return	+6.8%	+9.4%	+8.3%	+6.4%	+5.9%